H.C. Wainwright Initiates DARA Biosciences With Buy

Analysts at H.C. Wainwright initiated coverage on

with a Buy rating. The target price for DARA Biosciences is set to $2. DARA Biosciences shares have dropped 59.04 percent over the past 52 weeks, while the S&P 500 index has surged 13.39 percent in the same period. DARA Biosciences' shares rose 3.90 percent to $0.800 in pre-market trading.